BIVI

Biovie Inc

NASDAQ: BIVI · HEALTHCARE · BIOTECHNOLOGY

$1.93

+1.05% today

Updated 2026-09-11

Market cap

$16.31M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.05

Dividend yield

—

52W range

$1 – $4

Volume

5.8M

Market cap

$16.31M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.05

Dividend yield

—

52W range

$1 – $4

Volume

5.8M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

7.3

Quality

B+

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

$5.25

+172.02%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.03x — low leverage

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-4.12M

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	2026	TTM
Revenue	$0.00	$0.00	$0.00	—	—
Net income	$-50.26M	$-32.12M	$-17.54M	$-22.07M	$-5.65M
EPS	—	—	—	—	$-3.05
Free cash flow	$-40.25M	$-27.95M	$-19.03M	$-19.02B	$-4.12M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BIVI	$16.31M	25	4.3	3.0	5.0	7.3	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	2.7	6.0	-88.93%	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-69.36%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-73.74%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	6.0	-16.10%	Buy

Smart narrative

Biovie Inc trades at $1.93. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is Biovie Inc's stock price?

Biovie Inc (BIVI) trades at $1.93.

Is Biovie Inc overvalued?

Biovie Inc carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Biovie Inc (BIVI)?

The 12-month analyst consensus target is $5.25, about 172.0% above the current $1.93. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

bioviepharma.com

Quick metrics

P/S ratio—

ROE-127.61%

Beta0.74

50D MA$1.73

200D MA$1.51

Shares out0.01B

Float0.01B

Short ratio—

Avg volume5.8M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BIVI vs LLY →BIVI vs JNJ →BIVI vs ABBV →Stock screener →